DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

54 hedge funds and large institutions have $313M invested in Dicerna Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+7
Holders Change %
+14.89%
% of All Funds
1.44%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
14
Increased
17
Reduced
15
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
$59.7M
2
O
OrbiMed
New York
$4.69M
3
ICM
ISZO Capital Management
New York
$2.96M
4
EA
Emerald Advisers
Pennsylvania
$1.55M
5
Invesco
Invesco
Georgia
$1.51M

Top Sellers

1
A
Abingworth
United Kingdom
$23.4M
2
RI
RTW Investments
New York
$23.8M
3
SFM
Sphera Funds Management
Israel
$0
4
OFM
Omega Fund Management
Massachusetts
$8.66M
5
TCM
Tekla Capital Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Barclays
51
Barclays
United Kingdom
$3K -$2.49K -92 -45%
BNP Paribas Financial Markets
52
BNP Paribas Financial Markets
France
$1.78K +$1.78K +74 New
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$15 – – –
SFM
54
Sphera Funds Management
Israel
– -$2.91M -176,802 Closed
TCM
55
Tekla Capital Management
Massachusetts
– -$2.57M -156,250 Closed
SM
56
Sabby Management
Florida
– -$2.4K -145,919 Closed
BCM
57
Bourgeon Capital Management
Connecticut
– -$412K -25,000 Closed
AL
58
Airain Ltd
Guernsey
– -$173K -10,500 Closed
BG
59
BlackRock Group
United Kingdom
– -$54K -3,277 Closed
1 2
3